SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,984.56645577 USD and is down -1.38 over the last 24 hours. It is currently trading on 12773 active market(s) with $23,404,967,729.76 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins slide toward the $75K$77K support area is the main focus, with traders citing the Binance hack and broader crypto-security concerns alongside election uncertainty as possible headwinds. Bearish traders warn of further losses if support breaks, while bulls argue the level is holding and are buying the dip.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is drawing attention amid a market pullback tied to weakness in technology and AI stocks, with traders pointing to doubts about AI spending and debt. The community is split between expecting more downside and seeing an oversold dip, while midterm-election uncertainty and the Iran conflict add to volatility concerns.

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 636,883,313.16514313 with 590,206,315.78603745 in circulation. The last known price of Solana is 92.37097662 USD and is down -1.79 over the last 24 hours. It is currently trading on 1189 active market(s) with $2,843,805,655.98 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

Solanas slide through a key psychological support amid broader crypto weakness is driving bearish chart talk, with traders watching for further downside. The Binance security incident has added to market-wide confidence concerns, though some traders say SOL was already under pressure; views remain split between shorting or expecting more losses and buying the dip to stake.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs upcoming earnings report is drawing attention after Intels weak outlook helped drive a broader semiconductor selloff. Traders are divided over whether strong results and guidance could steady the AI-chip trade or whether market-wide tech weakness and high expectations could pressure shares even after a beat.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,183,191.98331761. The last known price of Ethereum is 2,253.7325803 USD and is down -0.72 over the last 24 hours. It is currently trading on 14237 active market(s) with $11,299,510,487.72 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Binances reported major hack is weighing on Ethereum amid a broader crypto selloff, with traders focused on exchange security, withdrawals and the risk of further selling. The community is split between viewing the decline as a buying opportunityciting Binances efforts to cover lossesand expecting more downside and lingering damage to confidence.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARAs steep slide to fresh 52-week lows is fueling concern about its Bitcoin-linked volatility and the lack of signed AI/HPC tenant deals to validate its business pivot, with traders also looking ahead to earnings for possible lease news. The community is split between bearish calls for further losses and dip-buyers who see oversold conditions and high short interest as potential for a rebound.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a broad selloff in AI infrastructure and neocloud stocks, as traders debate whether debt and financing risks, GPU depreciation, and uncertain returns on AI spending threaten the sectors growth story. Bears see further downside and a possible AI-bubble unwind, while bulls argue the drop is an overshoot and point to continued demand for compute.

Cardano (ADA) is a cryptocurrency launched in 2017. Cardano has a current supply of 44,994,665,205.855202 with 36,823,860,963.224877 in circulation. The last known price of Cardano is 0.18956469 USD and is down -1.68 over the last 24 hours. It is currently trading on 1752 active market(s) with $215,011,959.13 traded over the last 24 hours. More information can be found at https://www.cardano.org.

Cardano

Cardano is drawing attention amid a weak crypto market, with traders flagging bearish technical signals and lost support while others view the decline as a buying opportunity and expect a rebound. Sentiment is sharply divided between claims that ADA could keep sliding and speculative hopes for a breakout or short squeeze.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axons proposed zero-coupon convertible-note offering has fueled dilution concerns and added to a sharp, volatile selloff, alongside worries about valuation and margin pressure. Bulls see the weakness as a buying opportunity based on the companys growth and public-safety business, while bears remain focused on dilution and profitability.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells planned all-stock acquisition of Lumentum has sparked a sharp selloff, with traders focused on dilution, the deals size and long wait to close. Some see the move as an expensive risk to shareholders, while others argue combining Marvells connectivity technology with Lumentums optical assets could strengthen its position in AI data centers.

statis crypto Watchlist

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: Nuvilex (NASDAQ:PMCB) Director Acquires 20,000 Shares of Stock

Nuvilex Inc. (NASDAQ:PMCB - Get Free Report) Director Jonathan Schechter purchased 20,000 shares of Nuvilex stock in a transaction that occurred on Monday, January 5th. The shares were bought at an...

PMCB Stock Jumps 25% After Company Sells Stake In Femasys

Equity

PharmaCyte noted that it now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash.


PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.

PharmaCyte Biotech Inc

Bullish Sentiment

<ul class="summary-bullets"><li>The stake sale comes on the heels of the company increasing its stake in TNF Pharmaceuticals in September by an additional $3 million.&nbsp;</li><li>PharmaCyte said that it plans to continue pursuing value-accretive investment opportunities and disciplined operational management.&nbsp;</li><li>The company said that monetizing its stake in Femasys will help strengthen its financial position.</li></ul> PharmaCyte Biotech, Inc. (PMCB) said on Tuesday that it sold its stake in Femasys Inc. (FEMY), thereby increasing its cash and marketable securities to about $20 million.The company had cash and marketable securities of only about $13.3 million as of the end of July. The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.pharmacyte.com/press-releases/detail/319/pharmacyte-biotech-successfully-monetizes-femasys-stake">said</a> that monetizing its stake in Femasys will help strengthen its financial position.Shares of <a href="https://stocktwits.com/symbol/PMCB">PMCB </a>traded 25% higher at the time of writing.<h2 class="st-heading-2">PharmaCyte’s Financial Position</h2>CEO Josh Silverman stated that the successful monetization of the Femasys position demonstrates the effectiveness of the strategic and disciplined capital allocation approach. “We are committed to deploying shareholder capital intelligently, balancing near-term returns with opportunities that can deliver sustained value creation,” he said.Overall, PharmaCyte now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash. The company highlighted its low stock price below $1 and added that it plans to continue pursuing value-accretive investment opportunities and disciplined operational management.The stake sale comes on the heels of the company increasing its stake in Q/C Technologies, formerly known as TNF Pharmaceuticals, in September by an additional $3 million.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around PMCB jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.A Stocktwits user opined that the news shows the company has ways to generate cash without doing share offerings.<stembedurl>https://stocktwits.com/MadBat/message/637404061</stembedurl>Another expects the stock to cross the $1 threshold.<stembedurl>https://stocktwits.com/cbt2020/message/637412358</stembedurl>PMCB stock fell 48% this year and by about 53% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nio-stock-slips-after-q4-revenue-guidance-disappoints/cL52NcEREgI">Nio Stock Slips After Q4 Revenue Guidance Disappoints</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

PharmaCyte noted that it now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash.

Femasys Inc

Q/C Technologies Inc.

Up more than 3%

Flat to up 3%

Flat to down 3%

Down more than 3%

What’s your expected total return for the S&amp;P 500 ($SPY) in November?

Stocktwits

What’s your expected total return for the S&P 500 (

Feed

News

Sentiment

Earnings

Fundamentals

Info

PMCB PharmaCyte Biotech Inc

Fundamentals

Latest PMCB News